[Not Available].

Introduction: This study observes the results of outbreak and mortality in three comparable countries that have been widely affected: Belgium, the Netherlands, Sweden. These countries carried out “non-pharmaceutical interventions” at three different levels, from lockdown (Belgium) to social distancing (Sweden).

Objective: This study examines the effectiveness of general and undifferentiated interventions (lockdown) and their side effects.

Time trends in cardiovascular and all-cause mortality in the 'old' and 'new' European Union countries.

Aims: There are large differences in all-cause and cardiovascular disease (CVD) mortality between eastern and western countries in Europe. We reviewed the development of these mortality trends in countries of the European Union (EU) over the past 40 years and evaluated available data regarding possible determinants of these differences.

Methods And Results: We summarized all-cause mortality and specific cardiovascular mortality for two country groups - 10 countries that joined the European Union (EU) after 2004 (East), and 15 countries that joined before 2004 (West).

Unexpected rescue of alpha-synuclein and multimerin1 deletion in C57BL/6JOlaHsd mice by beta-adducin knockout.

Uniform genetic background of inbred mouse strains is essential in experiments with genetically modified mice. In order to assess Add2 (beta-adducin) function, its null mutation was produced in embryonic stem cells derived from 129Sv mouse and the subsequently obtained mouse mutants were backcrossed for 6 generations with C57BL/6JOlaHsd strain. Comparison of brain proteins between mutated and control animals by two-dimensional gels linked to mass spectroscopy analysis showed expression of Snca (alpha-synuclein) in the mutated animals, but unexpectedly not in the control C57BL/6JOlaHsd mice.